Publication: 186

Publication: 186

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 25 (23) 3456-61

Year:: 2007
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: 2 U10 CA33601-25

Corr. Author:
Authors:: Leonard B Saltz Donna Niedzwiecki Donna Hollis Richard M Goldberg Alexander Hantel James P Thomas Anthony L A Fields Robert J Mayer

Networks:

Study: Alliance-89803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:

Keywords:: Adult, Aged, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, Disease-Free Survival, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Neoplasm Metastasis, Prognosis, Treatment Outcome